IT15 gene expression in fetal human brain

To examine the expression of the gene which causes Huntington's disease (HD), IT15, during development, in situ hybridization of radiolabeled riboprobes was performed in human fetal (gestational ages 20-23 weeks) and adult brain. Optical densities of autoradiographs were determined in various brain regions and compared to cell density in those regions. IT15 expression was found in all regions of the fetal and adult brain, and there was a high degree of correlation of autoradiographic signal with cell number in all regions but germinal matrix in fetal brain and white matter in adult brain. These two regions are notable for their significant proportion of glial cells, and suggest that IT15 expression is predominantly neuronal. There was no preponderance of IT15 expression in striatal compartments in fetal brain as demonstrated by acetylcholinesterase activity, nor was there differential expression of IT15 in brain regions known to be particularly affected in HD. IT15 gene expression is present by 20 weeks gestation in human brain, and at that stage of development exhibits a pattern of distribution which is similar to adult brain. If a developmentally-regulated role for IT15 exists in the pathogenesis of HD, it must occur prior to 20 weeks gestation.

[1]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[2]  G. Bruyn,et al.  Pathogenesis of Huntington's chorea. , 1973, Lancet.

[3]  O. Onodera,et al.  Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.

[4]  E. J. Field,et al.  UNSATURATED FATTY ACIDS AND TRANSPLANTATION , 1975, The Lancet.

[5]  J. Coyle,et al.  Cytotoxic lesions and the development of transmitter systems , 1982, Trends in Neurosciences.

[6]  S. Gould,et al.  AN IMMUNOHISTOCHEMICAL STUDY OF THE GERMINAL LAYER IN THE LATE GESTATION HUMAN FETAL BRAIN , 1987, Neuropathology and applied neurobiology.

[7]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[8]  S. Folstein,et al.  Huntington's disease gene (IT15) is widely expressed in human and rat tissues , 1993, Neuron.

[9]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[10]  H. Fibiger,et al.  Loss of striatal somatostatin neurons following prenatal methylazoxymethanol , 1990, Experimental Neurology.

[11]  C. W. Ragsdale,et al.  Clumping of acetylcholinesterase activity in the developing striatum of the human fetus and young infant. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Penney,et al.  Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity‐akinesia , 1990, Annals of neurology.

[13]  P. Rakic,et al.  Immunoperoxidase localization of glial fibrillary acidic protein in radial glial cells and astrocytes of the developing rhesus monkey brain , 1980, The Journal of comparative neurology.

[14]  Y. Yoneda,et al.  Excitatory amino acid receptors in brains of rats with methylazoxymethanol-induced microencephaly , 1992, Neuroscience Research.

[15]  L. Lapham,et al.  Radial glia in the human fetal cerebrum: A combined golgi, immunofluorescent and electron microscopic study , 1978, Brain Research.

[16]  R H Myers,et al.  Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus , 1991, Journal of neuropathology and experimental neurology.

[17]  M. MacDonald,et al.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease , 1993, Nature Genetics.

[18]  J. Coyle,et al.  AF64A: An Active Site Directed Irreversible Inhibitor of Choline Acetyltransferase , 1985, Journal of neurochemistry.

[19]  M. Johnston,et al.  Use of toxins to disrupt neurotransmitter circuitry in the developing brain. , 1988, Progress in brain research.

[20]  R. Albin,et al.  Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues , 1993, Nature Genetics.

[21]  R. Burke,et al.  Localization of c-fos, c-jun, and hsp70 mRNA expression in brain after neonatal hypoxia-ischemia. , 1994, Brain research. Developmental brain research.

[22]  Finn A. GENnS.  Distribution of Acetyl Cholinesterase in the Hippocampal Region of the Guinea Pig , 1972 .

[23]  M. MacDonald,et al.  Gametic but not somatic instability of CAG repeat length in Huntington's disease. , 1993, Journal of medical genetics.

[24]  J. B. Martin,et al.  Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.

[25]  Joseph B. Martin,et al.  Morphologic and Histochemical Characteristics of a Spared Subset of Striatal Neurons in Huntington's Disease , 1987, Journal of neuropathology and experimental neurology.

[26]  A. Fleming,et al.  REGRESSION OF HODGKIN'S DISEASE AFTER MEASLES , 1981, The Lancet.

[27]  D. Nelson,et al.  Trinucleotide repeat expansions in neurological disease , 1993, Current Opinion in Neurobiology.

[28]  C. L. Warner,et al.  Meiotic stability and genotype – phenotype correlation of the trinucleotide repeat in X–linked spinal and bulbar muscular atrophy , 1992, Nature Genetics.

[29]  C. Hudson,et al.  Evidence for transient perinatal glutamatergic innervation of globus pallidus , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  P. Emson,et al.  Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease , 1985, Brain Research.

[31]  J. Gusella,et al.  Huntington's disease. Pathogenesis and management. , 1986, The New England journal of medicine.

[32]  G. Bruyn,et al.  Letter: Pathogenesis of Huntington's chorea, Pick's disease, and paralysis agitans. , 1974, Lancet.

[33]  J. Penney,et al.  Differential loss of striatal projection neurons in Huntington disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Rakić,et al.  Early divergence and changing proportions of neuronal and glial precursor cells in the primate cerebral ventricular zone. , 1983, Developmental biology.

[35]  M. Hayden,et al.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.

[36]  A. Graybiel,et al.  Chemospecificity of ontogenetic units in the striatum: demonstration by combining [3H]thymidine neuronography and histochemical staining. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Vonsattel,et al.  Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.

[38]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[39]  J. Coyle,et al.  Selective cholinergic neurotoxin: AF64A's effects in rat striatum , 1984, Brain Research.

[40]  J. Penney,et al.  Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.

[41]  J. Coyle,et al.  Effects of Fetal Methylazoxymethanol Acetate Lesion on the Synaptic Neurochemistry of the Adult Rat Striatum , 1981, Journal of neurochemistry.

[42]  A. Sano,et al.  Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p , 1994, Nature Genetics.

[43]  F. Bieber,et al.  The Malformed Fetus and Stillbirth: A Diagnostic Approach , 1988 .